184 related articles for article (PubMed ID: 35955438)
21. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X
Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005
[No Abstract] [Full Text] [Related]
22. Comprehensive clinicopathological significance and putative transcriptional mechanisms of Forkhead box M1 factor in hepatocellular carcinoma.
Wu HY; Luo LF; Wei F; Jiang HM
World J Surg Oncol; 2023 Nov; 21(1):366. PubMed ID: 38001498
[TBL] [Abstract][Full Text] [Related]
23. LXRα-mediated downregulation of FOXM1 suppresses the proliferation of hepatocellular carcinoma cells.
Hu C; Liu D; Zhang Y; Lou G; Huang G; Chen B; Shen X; Gao M; Gong W; Zhou P; Dai S; Zeng Y; He F
Oncogene; 2014 May; 33(22):2888-97. PubMed ID: 23812424
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of CIP2A attenuates tumor progression by inducing cell cycle arrest and promoting cellular senescence in hepatocellular carcinoma.
Yang X; Qu K; Tao J; Yin G; Han S; Liu Q; Sun H
Biochem Biophys Res Commun; 2018 Jan; 495(2):1807-1814. PubMed ID: 29175329
[TBL] [Abstract][Full Text] [Related]
25. Expression of FOXM1 and Aurora-A predicts prognosis and sorafenib efficacy in patients with hepatocellular carcinoma.
Su WL; Chuang SC; Wang YC; Chen LA; Huang JW; Chang WT; Wang SN; Lee KT; Lin CS; Kuo KK
Cancer Biomark; 2020; 28(3):341-350. PubMed ID: 32390596
[TBL] [Abstract][Full Text] [Related]
26. [Differential analysis of gene expression profiles in hepatocellular carcinoma patients with high and low levels of alpha-fetoprotein].
Wang XJ; Shen RF; Wang X; Wang YR; Xiao T
Zhonghua Zhong Liu Za Zhi; 2020 May; 42(5):396-402. PubMed ID: 32482029
[No Abstract] [Full Text] [Related]
27. FOXM1-CD44 Signaling Is Critical for the Acquisition of Regorafenib Resistance in Human Liver Cancer Cells.
Wuputra K; Hsiao PJ; Chang WT; Wu PH; Chen LA; Huang JW; Su WL; Yang YH; Wu DC; Yokoyama KK; Kuo KK
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887129
[TBL] [Abstract][Full Text] [Related]
28. Liver X receptor inhibits the growth of hepatocellular carcinoma cells via regulating HULC/miR-134-5p/FOXM1 axis.
He J; Yang T; He W; Jiang S; Zhong D; Xu Z; Wei Q; Zhang Y; Shi C
Cell Signal; 2020 Oct; 74():109720. PubMed ID: 32711110
[TBL] [Abstract][Full Text] [Related]
29. A gene expression signature of FOXM1 predicts the prognosis of hepatocellular carcinoma.
Song BN; Chu IS
Exp Mol Med; 2018 Jan; 50(1):e418. PubMed ID: 29303511
[TBL] [Abstract][Full Text] [Related]
30. Effects of alpha-fetoprotein on the occurrence and progression of hepatocellular carcinoma.
Zheng Y; Zhu M; Li M
J Cancer Res Clin Oncol; 2020 Oct; 146(10):2439-2446. PubMed ID: 32725355
[TBL] [Abstract][Full Text] [Related]
31. Suppression of Hepatocellular Carcinoma Progression through FOXM1 and EMT Inhibition via Hydroxygenkwanin-Induced miR-320a Expression.
Chou LF; Chen CY; Yang WH; Chen CC; Chang JL; Leu YL; Liou MJ; Wang TH
Biomolecules; 2019 Dec; 10(1):. PubMed ID: 31877715
[No Abstract] [Full Text] [Related]
32. Cellular senescence in hepatocellular carcinoma induced by a long non-coding RNA-encoded peptide PINT87aa by blocking FOXM1-mediated
Xiang X; Fu Y; Zhao K; Miao R; Zhang X; Ma X; Liu C; Zhang N; Qu K
Theranostics; 2021; 11(10):4929-4944. PubMed ID: 33754036
[No Abstract] [Full Text] [Related]
33. LncRNA MFI2-AS1 promotes HCC progression and metastasis by acting as a competing endogenous RNA of miR-134 to upregulate FOXM1 expression.
Wei Y; Wang Z; Zong Y; Deng D; Chen P; Lu J
Biomed Pharmacother; 2020 May; 125():109890. PubMed ID: 32106369
[TBL] [Abstract][Full Text] [Related]
34. Knockdown of FoxM1 by siRNA interference decreases cell proliferation, induces cell cycle arrest and inhibits cell invasion in MHCC-97H cells in vitro.
Wu QF; Liu C; Tai MH; Liu D; Lei L; Wang RT; Tian M; Lü Y
Acta Pharmacol Sin; 2010 Mar; 31(3):361-6. PubMed ID: 20154714
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis B virus X protein upregulates alpha-fetoprotein to promote hepatocellular carcinoma by targeting miR-1236 and miR-329.
Zhang C; Liu P; Zhang C
J Cell Biochem; 2020 Mar; 121(3):2489-2499. PubMed ID: 31680299
[TBL] [Abstract][Full Text] [Related]
36. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
37. Expression of β-catenin protein in hepatocellular carcinoma and its relationship with alpha-fetoprotein.
Ren YJ; Huang T; Yu HL; Zhang L; He QJ; Xiong ZF; Peng H
J Huazhong Univ Sci Technolog Med Sci; 2016 Dec; 36(6):846-851. PubMed ID: 27924522
[TBL] [Abstract][Full Text] [Related]
38. Autophagic protein ULK1 regulates FOXM1 signalling in human hepatoma cells.
Rajak S; Raza S; Tewari A; Yadav S; Ghosh S; Yen PM; Sinha RA
Biochem Biophys Res Commun; 2020 Nov; 532(4):570-575. PubMed ID: 32900486
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive analysis of FOXM1 immune infiltrates, m6a, glycolysis and ceRNA network in human hepatocellular carcinoma.
Xu Z; Pei C; Cheng H; Song K; Yang J; Li Y; He Y; Liang W; Liu B; Tan W; Li X; Pan X; Meng L
Front Immunol; 2023; 14():1138524. PubMed ID: 37234166
[TBL] [Abstract][Full Text] [Related]
40. Sequential Treatment with Activin and Hepatocyte Growth Factor Induces FOXM1 to Promote Colorectal Cancer Liver Metastasis.
Peng H; Ye T; Deng L; Yang X; Jiang Z; Guo J
Can J Gastroenterol Hepatol; 2022; 2022():8996203. PubMed ID: 36591565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
